Abstract
The mosaic theory continues to command the center of hypertension research. Burton (40) was the first to show that any theory for control of blood pressure must rest on some fundamental principles of equilibrium of the arterioles. Page (176) subsequently argued that the problem of hypertension may be “more realistically soluble in terms of altered equilibria than by any one of a variety of monistic approaches.” He later brought the theory to bear on renal hypertension (175,177), the center being the physical equilibrium of the arteriole, with factors such as genetic, environmental, anatomical, adaptive, neural, endocrine, humoral, and hemodynamic forming the margin. Thus, most theoretical discourse focuses on renal hypertension, because it has been acknowledged that the pathogenesis is very similar to human essential hypertension (18). The purpose of this chapter is to review the conceptual understanding of the problem of hypertension in general, taking renal hypertension as a marginal model for the pathogenesis of the disease in blacks.
At its inception, the mosaic theory was portrayed as an octagon with the then known regulators on each focal point and arrows indicating a closed system in equilibrium…. [genetic, environmental, anatomical, adaptive, neural, endocrine, humoral, hemodynamic]. Clearly, this… is not meant to list all of the multiple mechanisms currently adumbrated as constituting the many facets of hypertension considered as a “disease of regulation.” Rather, the mosaic concept is intended to provide a logical and orderly way of thinking about all forms of hypertension as a subject for research and as a means of analyzing the problem in patients.
I. H. Page
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackerman, U. Cardiac output, GFR, and renal excretion rates during maintained volume load in rats. Am. J. Physiol. 235 (Heart Circ. Physiol. 4): H670 — H676, 1978.
Amer, M. S., I. V. Doba, and D. J. Reis. Changes in cyclic nucleotide metabolism in aorta and heart of neurogenically hypertensive rats: possible trigger mechanism of hypertension. Proc. Natl. Acad. Sci. U.S.A. 72: 2135–2139, 1975.
Anderson, N. B., H. F. Myers, T. Pickering, and J. S. Jackson. Hypertension in blacks: psychosocial and biological perspectives. J. Hypertens. 7: 161–172, 1989.
Andresen, M. C., J. M. Krauhs, and A. M. Brown. Relationship of aortic wall and baroreceptor properties during development in normotensive sportaneously hypertensive rats. Circ. Res. 43: 728–738, 1978.
Andresen, M. C., S. Kuraoka, and A. M. Brown. Individual and combined actions of calcium, sodium, and postassium ions or baroreceptors in the rat. Circ. Res. 45: 757–763, 1979.
Angell-James, J. E. Characteristics of single aortic and right subclavian baroreceptor fiber activity in rabbits with chronic renal hypertension. Circ. Res. 32: 149–161, 1973.
Aoki, K., and K. Sato. Pathophysiological background for the use of calcium antagonists. J. Cardiovasc. Pharmacol. 7 (Supp.4): S28 — S32, 1985.
Aviv, A. The link between cytosolic Ca“ and the Na’–H antiport: a unifying factor for essential hypertension. J. Hypertens. 6: 685–691, 1988.
Azuma, T., and S. Oka. Mechanical equilibrium of blood vessel walls. Am. J. Physiol. 221: 1310–1318, 1971.
Baez, S. Bayliss response in the microcirculation. Fed. Proc. 27: 1410–1415, 1968.
Barger, A. C. The Goldblatt memorial lecture, part I: experimental renovascular hypertension. Hypertension 1: 447–455, 1979.
Bauer, J. H., and G. Reams. Short-and long-term effects of calcium entry blockers on the kidney. Am. J. Cardiol. 59: 66A - 71A, 1987.
Bauer, J. H., S. Sunderrajan, and G. Reams. Effects of calcium entry blockers on reninangiotensin—aldosterone system, renal function and hemodynamics, salt and water excretion, and body fluid composition. Am. J. Cardiol. 56: 62H - 67H, 1985.
Bayliss, W. M. On the local reactions of the arterial wall to changes of internal pressure. J. Physiol. (Lond.) 28: 220–231, 1902.
Bell, L. B., J. L. Seagard, E. J. Zuperku, and J. P. Kampine. Mechanical effects of vaso-active drugs on carotid sinus. Am. J. Physiol. 250 (Regulatory Integrative Comp. Physiol. 20:) R1074 - R1080, 1986.
Berecek, K. H., U. Schwertschlag, and F. Gross. Alterations in renal vascular resistance and reactivity in spontaneous hypertension of rats. Am. J. Physiol. 238 (Heart Circ. Physiol. 8): H287 - H293, 1980.
Bevan, J. A. Diltiazem selectively inhibits cerebrovascular extrinsic but not intrinsic myogenic tone. Circ. Res. 52 (Suppl.I): 104–109, 1983.
Bianchi, G., D. Cusi, M. Gatti, G. P. Lupi, P. Ferrari, C. Barlassina, G. B. Picotti, G. Bracchi, G. Colombo, D. Gori, O. Velis, and D. Mazzei. A renal abnormality as a possible cause of “essential” hypertension. Lancet 1: 173–177, 1979.
Bianchi, G., U. Fox, D. Pagetti, A. M. Caravaggi, P. G. Baer, and E. Baldoli. Mechanism involved in renal hypertension. Kidney Int. 8: S165 - S173, 1975.
Blaustein, M. P. How salt causes hypertension: the natriuretic hormone-Na/Ca exchange-hypertension hypothesis. Klin. Wochenschr. 63 (Suppl III): 82–85, 1985.
Blaustein, M. P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am. J. Physiol. 232 (Cell Physiol. 2): C165 - C173, 1977.
Blaustein, M. P., and J. M. Hamlyn. Sodium transport inhibition, cell calcium, and hypertension. The natriuretic hormone/Na+-Ca2+ exchange/hypertension hypothesis. Am. J. Med. 77 (Supp.4A): 45–59, 1984.
Bolli, P., P. Erne, U. L. Hulthen, R. Ritz, W. Kiowski, B. H. Ji, and F. R. Buhler. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and B-adrenoreceptor blockade. J. Cardiovasc. Pharmacol. 6: S996 - S1001, 1984.
Bolli, P., W. Kiowski, P. Erne, L. U. Hulthen, and F. R., Buhler. Hemodynamic and anti-hypertensive treatment responses with calcium antagonists. J. Cardiovasc. Pharmacol. 7: S126 - S130, 1985.
Bolt, G. R., and P. R. Saxena. Acute systemic and regional hemodynamic effects of felodipine, a new calcium antagonist, in conscious renal hypertensive rabbits. J. Cardiovasc. Pharmacol. 6: 707–712, 1984.
Borgstrom, P., P-O. Grande, and L. Lindbom. Responses of single arterioles in vivo in cat skeletal muscle to change in arterial pressure applied at different rates. Acta Physiol. Scand. 113: 207–212, 1981.
Borst, J. G. G., and A. Borst-DeGeus. Hypertension explained by Starling’s theory of circulatory homeostasis. Lancet 1: 677–682, 1963.
Brostrom, C. O. and M. A. Brostrom. Calcium-dependent regulation of protein synthesis in intact mammalian cells. Ann. Rev. Physiol. 52: 577–590, 1990.
Brown, J. J., A. F. Lever, J. I. S. Robertson, M. A. Schalekamp. Renal abnormality of essential hypertension. Lancet 1: 320–323, 1974.
Brunner, H. R., J. Nussberger, and B. Waeber. Responsiveness of renin secretion: a key mechanism in the maintenance of blood pressure. J. Hypertens. 4 (Supp.IV): S89 - S94, 1986.
Bruschi, G., M. E. Bruschi, A. Cavatorta, and A. Borghetti. The mechanisms of Cai2+ increases in blood cells of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 8 (Supp. 8): S139 - S144, 1986.
Bruschi, G., M. E. Bruschi, M. Caroppo, G. Orlandini, M. Spaggiari, and A. Cavatorta. Cytoplasmic free [Ca2+1 is increased in the platelets of spontaneously hypertensive rats and essential hypertensive patients. Clin. Sci. 68: 179–184, 1985.
Bruschi, G., M. E. Bruschi, M. Caroppo, G. Orlandini, C. Pavarini, and A. Cavatorta. Intracellular free [Ca2a] in circulating lymphocytes of spontaneously hypertensive rats. Life Sci. 35: 535–542, 1984.
Bryant, H. J., D. R. Harder, M. B. Pamnani, and F. J. Haddy. In vivo membrane potentials of smooth muscle cells in the caudal artery of the rat. Am. J. Physiol. 249 (Cell Physiol. 18): C78 - C83, 1985.
Buggy, J., S. Huot, M. Pamnani, and F. Haddy. Periventricular forebrain mechanisms for blood pressure regulation. Fed. Proc. 43: 25–31, 1984.
Buhler, F. R., P. Bolli, Erne, W. Kiowski, F. B. Muller, U. L. Hulthen, and B. H. Ji. Adrenoceptors, calcium, and vasoconstriction in normal and hypertensive humans. J. Cardiovasc. Pharmacol. 7 (Suppl.6): 130–136, 1985.
Burke, S. L., P. K. Dorward, and P. I. Korner. Rapid resetting of rabbit aortic baroreceptors and reflex heart rate responses by directional changes in blood pressure. J. Physiol. (Lond) 378: 391–402, 1986.
Burrows, M. E., and P. C. Johnson. Arteriolar responses to elevation of venous and arterial pressures in cat mesentery. Am. J. Physiol. 245 (Heart Circ. Physiol. 14): H796 - H807, 1983.
Burrows, M. E., and P. C. Johnson. Diameters, wall tension, and flow in mesenteric arterioles during autoregulation. Am. J. Physiol. 241 (Heart Circ. Physiol. 10): H829 - H837, 1981.
Burton, A. C. On the physical equilibrium of small blood vessels. Am. J. Physiol. 164: 319–329, 1951.
Capponi, A. M., P. D. Lew, L. Jornot, and M. B. Vallotton. Correlation between cytosolic free Ca“ and aldosterone production in adrenal glomerulosa cells. Evidence for a difference in the mode of action of angiotensin II and potassium. J. Biol. Chem. 259: 8863–8869, 1984.
Carafoli, E., and M. Zurini. The Ca“ -pumping ATPase of plasma membranes purification, reconstitution and properties. Biochim. Biophys. Acta 683: 279–301, 1982.
Cauvin, C., S. Lukeman, J. Cameron, O. Hwang, and C. VanBreemen. Differences in nor-epinephrine activation and diltiazem inhibition of calcium channels in isolated rabbit aorta and mesenteric resistance vessels. Circ. Res. 56: 822–828, 1985.
Chalmers, J. P., P. M. Pilowsky, J. P. Minson, V. Kapoor, E. Mills, and M. J. West. Central serotonergic mechanisms in hypertension. Am. J. Hypertens. 1: 79–83, 1988.
Chapman, R. A. Control of cardiac contractility at the cellular level. Am. J. Physiol. 245 (Heart Circ. Physiol. 14): H535 - H552, 1983.
Cheung, D. W. Membrane potential of vascular smooth muscle and hypertension in spontaneously hypertensive rats. Can. J. Physiol. Pharmacol. 62: 957–960, 1984.
Click, R. L., W. Joyner, and J. P. Gilmore. Reactivity of glomerular afferent and efferent arterioles in renal hypertension. Kidney Int. 15: 109–115, 1979.
Cohen, A. J., J. C. S. Fray. Calcium dependence of myogenic renal plasma flow autoregulation: evidence from the isolated perfused rat kidney. J. Physiol. (Lond.) 330: 449460, 1982.
Coleman, T. G., R. E. Samar, and W. R. Murphy. Autoregulation versus other vasoconstrictors in hypertension. Hypertension 1: 324–330, 1979.
Coleridge, H. M., J. C. G. Coleridge, M. P. Kaufman, and A. Dangel. Operational sensitivity and acute resetting of aortic baroreceptors in dogs. Circ. Res. 48: 676–684, 1981.
Constantopoulos, G., M. Kusumoto, J. M. Rojo-Ortega, P. Granger, R. Boucher, and J. Genest. Arterial water, cations, and norepinephrine in early and late renovascular hypertension. Am. J. Physiol. 228: 1415–1422, 1975.
Cooper, K. E., J. M. Tang, J. L. Rae, and R. S. Eisenberg. A cation channel in frog lens epithelia responsive to pressure and calcium. J. Membr. Biol. 93: 259–269, 1986.
Cooper, R. S., N. Shamsi, and S. Katz. Intracellular calcium and sodium in hypertensive patients. Hypertension 9: 224–229, 1987.
Cowley, A. W. The concept of autoregulation of total blood flow and its role in hypertension. Am. J. Med. 68: 906–916, 1980.
Cowley, A. W., C. Hinojosa-Labourde, B. J. Barber, D. R. Harder, J. H. Lombard, and A. S. Greene. Short-term autoregulation of systemic blood flow and cardiac output. News in Physiological Sciences 4: 219–225, 1989.
Dahl, L. K., K. D. Knudsen, and J. Iwai. Humoral transmission of hypertension: evidence from parabiosis. Circ. Res. 24 (Supp.I): 21–33, 1969.
Davis, J. O. The pathogenesis of chronic renovascular hypertension. Circ. Res. 40: 439444, 1977.
DeJong, W., ed. Experimental and Genetic Models of Hypertension, Elsevier, New York, 1984.
DeQuattro, V., and Y. Miura. Neurogenic factors inhuman hypertension: mechanism or myth ? Am. J. Med. 55: 362–378, 1973.
DeWardener, H. E., G. A. MacGregor. The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension. Medicine 62: 310–326, 1983.
DeWardener, H. E., and G. A. MacGregor. Dahl’s hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int. 18: 1–9, 1980.
Donnison, C. P. Blood pressure in the African native. Lancet 1: 6–7, 1929.
Doward, P. K., M. C. Andresen, S. L. Burke, J. R. Oliver, and P. I. Korner. Rapid resetting of the aortic baroreceptors in the rabbit and its implications for short-term and longer term reflex control. Circ. Res. 50: 428–439, 1982.
Dzau, V. J., L. G. Seiwek, and A. C. Barger. Intrarenal resistance in experimental hypertension. In: Frontiers in Hypertension Research, edited by J. H. Laragh, F. R. Buhler, and D. W. Seldin, Springer-Verlag, New York, 1981, pp. 165–168.
Edwards, C., D. Ottoson, B. Rydgvist, and C. Swerup. The permeability of the transducer membrane of the cray fish stretch receptor to calcium and other divalent cations. Neuroscience 6: 1455–1460, 1981.
Edwards, R. M. Segmental effect of norepinephrine and angiotensin II on isolated renal microvessels. Am. J. Physiol. 244 (Renal Fluid Electrolyte Physiol.13): F526 - F534, 1983.
Ene, M. D., P. J. Williamson, and C. J. C. Roberts. The natriuresis following oral administration of the calcium antagonists-nifedipine and nitrendipine. Br. J. Clin. Pharmacol. 19: 423–427, 1985.
Erne, P., E. Burgisser, P. Bolli, J. BaoHua, and F. R. Buhler. Free calcium concentration in platelets closely relates to blood pressure in normal and essential hypertensive subjects. Hypertension 6 (Supp.I): 166–169, 1984.
Erne, P., P. Bolli, E. Burgisser, and F. R. Buhler. Correlation of platelet calcium with blood pressure. N. Engl. J. Med. 310: 1084–1088, 1984.
Eller, M., S. Julius, A. Zweifler, O. Randall, E. Harburg, H. Gardiner, and V. DeQuattro. Mild high-renin essential hypertension: neurogenic human hypertension? N. Engl. J. Med. 296: 405–411, 1977.
Fakunding; J. T., and K. J. Catt. Dependence of aldosterone stimulation in adrenal glomerulosa cells on calcium uptake: effects of lanthanum and verapamil. Endocrinology 107: 1345–1353, 1980.
Fakunding, J L, R Chow, and K. J. Catt. The role of calcium in the stimulation of aldosterone production by adrenocorticotropin, angiotensin II, and potassium in isolated glomerulosa cells. Endocrinology 105: 327–333, 1979.
Firth, J. D., A. E. G. Raine, and J. G. G. Ledingham. The mechanism of pressure natriuresis. J. Hypertens. 8: 97–103, 1990.
Folkow, B. Physiological aspects of primary hypertension. Physiol. Rev. 62: 347–504, 1982.
Folkow, B., G. Grimby, and O. Thulesius. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol. Scand. 44: 255–272, 1958.
Foster, R., M. V. Lobo, H. Rasmussen, and E. T. Marusic. Calcium its role in the mechanism of action of angiotensin II and potassium in aldoesterone production. Endocrinology 109: 2196–2201, 1981.
Fray, J. C. S. Stretch receptor model for renin release with evidence from perfused rat kidney. Am. J. Physiol. 231: 936–944, 1976.
Fray, J. C. S., D. J. Lush, and C. S. Park. Interrelationship of blood flow, juxtaglomerular cells, and hypertension: role of physical equilibrium and Ca. Am. J. Physiol. 251 (Regulatory Integrative Comp. Physiol. 20): R643 - R662, 1986.
Fray, J. C S., C. S. Park, and A. N. D. Valentine. Calcium and the control of renin secretion. Endocr. Rev. 8: 1–42, 1987.
Freeman, R. H., J. O. Davis, and A. A. Seymour. Volume and vasoconstriction in experimental renovascular hypertension. Fed. Proc. 41: 2409–2414, 1982.
Frohlich, E. D. Hemodynamic factors in the pathogenesis and maintenance of hypertension. Fed. Proc. 41: 2400–2408, 1982.
Gothberg, G., and B. Folkow. “Structural autoregulation” of blood flow and GFR two-kidney, one-clip renal hypertensive rats, as compared with kidneys from uni-nephrectomized and intact normotensive rats. Acta Physiol. Scand. 118: 141–148, 1983.
Granger, H. J., A. C. Guyton. Autoregulation of the total sytemic circulation following destruction of the central nervous system in the dog. Circ. Res. 25: 379–388, 1969.
Grim, C. E., F C. Luft, J. Z. Miller, G. R. Meneely, H. D. Battarbee, C. G. Hames, and L. K. Dahl. Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J. Chronic Dis. 33: 87–94, 1980.
Grossman, E., and T. Rosenthal. The hypotensive effect of nisoldipine in renovascular hypertensive rats. J. Hypertens. 4 (Suppl. 5): S141–144, 1986.
Guharay, F., and F. Sachs. Mechanotransducer ion channels in chick skeletal muscle: the effects of extracellular pH. J. Physiol. (Lond.) 363: 119–134, 1985.
Guharay, F., and F. Sachs. Stretch-activated single ion channel currents in tissue-cultured embryonic chick skeletal muscle. J. Physiol. (Lond.) 352: 685–701, 1984.
Guo, G. B., and M. D. Thames. Abnormal baroreflex control in renal hypertension is due to abnormal baroreceptors. Am. J. Physiol. 245 (Heart Circ. Physiol. 14): H420 - H428, 1983.
Guyton, A. C., J. E. Hall, T. E. Lohmeier, R. D. Manning, and T. E. Jackson. Position paper: the concept of whole body autoregulation and the dóminant role of the kidneys for long-term blood pressure regulation. In: Frontiers in Hypertension Research, edited by J. H. Laragh, F. R. Buhler, and D. W. Seldin. Springer-Verlag, New York, 1981, pp. 125–134.
Guyton, A. C., R. D. Manning, J. E. Hall, R. A. Norman, D. B. Young, and Y.-J. Pan. The pathogenic role of the kidney. J. Cardiovasc. Pharmacol. 6 (Suppl.1): S151 — S161, 1984.
Guyton, A. C., R. D. Manning, R. A. Norman, J.-P. Montani, T. E. Lohmeier, and J. E. Hall. Current concepts and perspectives of renal volume regulation in relationship to hypertension. J. Hypertens. 4 (Supp.4): S49 — S56, 1986.
Guyton, A. C., T. G. Coleman, and H. J. Granger. Circulation: overall regulation. Ann. Rev. Physiol. 34: 13–46, 1972.
Haber, E. The role of renin in normal and pathological cardiovascular homeostasis. Circulation 54: 849–861, 1976.
Haddy, F. J. Abnormalities of membrane transport in hypertension. Hypertension 5 (Suppl.V): 66–72, 1983.
Haddy, F. J., and H. W. Overbeck. The role of humoral agents in volume expanded hypertension. Life Sci. 19: 935–948, 1976.
Haddy, F., M. Pamnani, and D. Clough. The sodium-potassium pump in volume expanded hypertension. Clin. Exp. Hypertens. 1: 295–336, 1978.
Haddy, F. J. and M. B. Pamnani. Natriuretic hormones in low renin hypertension. Klin. Wochensehr. 65 (Suppl. VIII): 154–160, 1987.
Hall, J. E. Control of sodium excretion by angiotensin II intrarenal mechanisms and blood pressure regulation. Am. J. Physiol. 250 (Regulatory Integrative Comp. Physiol. 19): R960 — R972, 1986.
Hall, J. E., J. P. Granger, R. L. Hester, and J.-P. Montani. Mechanisms of sodium balance in hypertension: role of pressure natriuresis. J. Hypertens. 4 (Supp.4): S57 — S65, 1986.
Hall, J. E., A. C. Guyton, M. J. Smith, and T. G. Coleman. Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am. J. Physiol. 239 (Renal Fluid Electrolyte Physiol. 8): F271 — F280, 1980.
Halpern, W., M. J. Mulvany, and D. M. Warshaw. Mechanical properties of smooth muscle cells in the walls of arterial resistance vessels. J. Physiol. (Lond.) 275: 85–101, 1978.
Hamlyn, J. M., and M. P. Blaustein. Sodium chloride, extracellular fluid volume, and blood pressure regulation. Am. J. Physiol. 251 (Renal Fluid Electrolyte Physiol. 20) F563 — F575, 1986.
Hamlyn, J. M., R. Ringel, J. Schaeffer, P. D. Levinson, B. P. Hamilton, A. A. Kowarski, and M. P. Blaustein. A circulating inhibitor of (Na +K’) ATPase associated with essential hypertension. Nature 300: 650–652, 1982.
Harder, D. R. Pressure-dependent membrane depolarization in cat middle cerebral artery. Circ. Res. 55: 197–202, 1984.
Heesch, C. M., B. M. Miller, M. D. Thames, and F. M. Abboud. Effects of calcium channel blockers on isolated carotid baroreceptors and baroreflex. Am. J. Physiol. 245 (Heart Circ. Physiol. 14): H653 — H661, 1983.
Henry, J. P., P. M. Stephens, and D. L. Ely. Psychosocial hypertension and the defence and defeat reactions. J. Hypertens. 4: 687–697, 1986.
Heymans, C., and A. L. Delaunois. Fundamental role of the tone and resistance to stretch of the carotid sinus arteries in the reflex regulation of blood pressure. Science 114: 546–547, 1951.
Hogestatt, E. D. Characterization of two different calcium entry pathways in small mesenteric arteries from rat. Acta Physiol. Scand. 122: 483–495, 1984.
Huang, W. C. Antihypertensive and bilateral renal responses to nifedipine in 2-kidney, 1-clip, Goldblatt hypertensive rats. Renal Physiol. 9: 167–176, 1986.
Hudspeth, A. J. The hair cells of the inner ear. Sci. Am. 248: 54–64, 1983.
Huelsemann, J. L., R. B. Sterzel, D. E. McKenzie, and C. S. Wilcox. Effects of a calcium entry blocker on blood pressure and renal function during angiotensin-induced hypertension. Hypertension 7: 374–379, 1985.
Humes, H. D., C. F. Simmons, and B. M. Brenner. Effect of verapamil on the hydroosmotic response to antidiuretic hormone in toad urinary bladder. Am. J. Physiol. 239 (Renal Fluid Electrolyte Physiol. 8): F250 — F257, 1980.
Hunt, C. C., R. S. Wilkinson, and Y. Fukami. Ionic basis of the receptor potential in primary endings of mammalian muscle spindles. J. Gen. Physiol. 71: 683–698, 1978.
Hwa, J. J., and J. A. Bevan. A nimodipine-resistant Ca“ pathway is involved in myogenic tone in a resistant artery. Am. J. Physiol. 251 (Heart Circ. Physiol. 20): H182 — H189, 1986.
Hwa, J. J., and J. A. Bevan. Stretch-dependent (myogenic) tone in rabbit ear resistance arteries. Am. J. Physiol. 250 (Heart Circ. Physiol. 19): H87 — H95, 1986.
Insel, P. A., and H. J. Motulsky. A hypothesis linking intracellular sodium, membrane receptors, and hypertension. Life Sci. 34: 1009–1013, 1984.
Iversen, B. M., L. Morkrid, and J. Ofstad. Afferent arteriolar diameter in DOCA-salt and two-kidney one-clip hypertensive rats. Am. J. Physiol. 245 (Renal Fluid Electrolyte Physiol. 14): F755 - F762, 1983.
Iversen, B. M., and J. Ofstad. Resetting of renal blood flow autoregulation and renin release in spontaneously hypertensive rats. Contrib. Nephrol. 41: 415–416, 1984.
Iversen, B. M., I. Sekse, and J. Ofstad. Resetting of renal blood flow autoregulation in spontaneously hypertensive rats. Am. J. Physiol. 252 (Renal Fluid Electrolyte Physiol. 21) F480 - F486, 1987.
Johansson, B. Processes involved in vascular smooth muscle contraction and relaxation. Circ. Res. 43: I-14-I-20, 1978.
Johnson, P. C., and M. Intaglietta. Contributions of pressure and flow sensitivity to autoregulation and mesenteric arterioles. Am. J. Physiol. 231: 1686–1698, 1976.
Joshua, I. G., F. N. Miller, and D. L. Wiegman. In vivo venular changes with the development of one-kidney, one-clip hypertension in the rat. Clin. Exper. Hypertens. A8: 1343–1354, 1986.
Kiowski, W., F. R. Buhler, M. O. Fadayomi, P. Erne, F. B. Muller, J. L. Hulthen, and P. Boli. Age, race, blood pressure and renin predictors for antihypertensive treatment with calcium antagonists. Am. J. Cardiol. 56: 81H - 85H, 1985.
Klein, W., D. Brandt, K. Vrecko, and M. Harringer. Role of calcium antagonists in the treatment of essential hypertension. Circ. Res. 52 (Suppl. I): 174–181, 1983.
Knight, D. R., D. A. Kirby, and S. R. Vatner. Effects of a calcium channel blocker on cardiac output distribution in conscious hypertensive dogs. Hypertension 7: 380–385, 1985.
Koch, A. R. Some mathematical forms of autoregulatory models. Circ. Res. 14 (Suppl. I): 260–278, 1964.
Kojima, I., K. Kojima, and H. Rasmussen. Effects of ANG II and K` on Ca efflux and aldosterone production in adrenal flomerulosa cells. Am. J. Physiol. 248 (Endocrinol. Metabl. 11) E43, 1985.
Kornel, L., N. Kanamarlapudi, and M. M. Von Dreele. The role of arterial mineralocorticoid receptors in the mechanism of hypertension: findings and hypothesis. Clin. Biochem. 20: 113–120, 1987.
Korner, P. I., G. L. Jennings, M. D. Elser, W. P. Anderson, A. Bobik, M. Adams, J. A. Angus. The cardiovascular amplifiers in human primary hypertension and their role in a strategy for detecting the underlying causes. Can. J. Physiol. Pharmacol. 65: 1730–1738, 1987.
Kowala, M. C., H. F. Cuenoud, I. Joris, and G. Majno. Cellular changes during hypertension: a quantitative study of the rat aorta. Exp. Molec. Pathol. 45: 323–335, 1986.
Krieger, E. M. Aortic diastolic caliber changes as a determinant for complete aortic baro-receptor resetting. Fed. Proc. 46: 41–45, 1987.
Kunze, D. L. Calcium and magnesium sensitivity of carotid baroreceptor reflex in cats. Circ. Res. 45: 815–821, 1979.
Kwan, C. Y., L. Belbeck, and E. E. Daniel. Characteristics of arterial plasma membrane in renovascular hypertension in rats. Blood Vessels 17: 131–140, 1980.
Kwan, C. Y., P. Kostka, A. K. Grover, J. S. Law, and E. E. Daniel. Calmodulin stimulation of plasmalemmal Cat+-pump of canine aortic smooth muscle. Blood Vessels 23: 2233, 1986.
Landgren, S. The baroreceptor activity in the carotid sinus nerve and the distensibility of the sinus wall. Acta Physiol. Scand. 26: 35–56, 1952.
Lansman, J. B., T. J. Hallam, and T. J. Rink. Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? Nature 325: 811–813, 1987.
Laragh, J. H. Renovascular hypertension: a paradigm for all hypertension J. Hypertens. 4 (Suppl. 4): S79 - S88, 1986.
Laragh, J. H. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am. J. Med. 55: 261–274, 1973.
Larsen, F. L., S. Katz, B. D. Roufogalis, and D. E. Brooks. Physiological shear stresses enhance the Cat+ permeability of human erythrocytes. Nature 294: 667–668, 1981.
Lau, K., and B. Eby. The role of calcium in genetic hypertension. Hypertension 7: 657667, 1985.
Ledingham, J. M. Mechanisms in renal hypertension. Proc. R. Soc. Med. 64: 409–418, 1971.
Ledingham, J. M., and R. D. Cohen. Hypertension explained by Starling’s theory of circulatory homeostasis. Lancet 1: 887–888, 1963.
Ledingham, J. M., and D. Pelling. Cardiac output and peripheral resistance in experimental renal hypertension. Circ. Res. 20 (Suppl.2): 187–199, 1967.
Lever, A. F. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J. Hypertens. 4: 515–524, 1986.
Levy, S. B., J. J. Lilley, R. P. Frigon, and R. A. Stone. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J. Clin. Invest. 60: 129–138, 1977.
Levy, S. B., L. B. Talner, M. H. Coel, R. Holle, and R. A. Stone. Renal vasculature in essential hypertension: racial differences. Ann. Intern. Med. 88: 12, 1978.
Liard, J. F. Regional blood flows in salt loading hypertension in the dog. Am. J. Physiol. 240 (Heart Circ. Physiol. 9): H361 - H367, 1981.
Losse, H., W. Zidek, and H. Vetter. Intracellular sodium and calcium in vascular smooth muscle of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 6: S32 - S34, 1984.
Lush, D. J., and J. C. S. Fray. Steady-state autoregulation of renal blood flow: a myogenic model. Am. J. Physiol. 247 (Regulatory Integretative Comp. Physiol. 16): R89 - R99, 1984.
MacGregor, G. A. Sodium is more important than calcium in essential hypertension. Hypertension 7: 628–637, 1985.
Majewski, H., and M. J. Rand. A possible role of epinephrine in the development of hypertension. Med. Res. Rev. 6: 467–486, 1986.
Marlettini, M. G., T. Salomone, M. Agostini, and M. De Novellis. Long-term treatment of primary hypertension with verapamil Curr. Ther. Res. 39: 59–65, 1986.
Massie, B. M. Antihypertensive therapy with calcium-channel blockers: comparison with beta blockers. Am. J. Cardiol. 56: 97H - 100H, 1985.
Massie, B. M., A. J. Hirsch, I. K. Inivye, and J. F. Tubau. Calcium channel blockers as antihypertensive agents. Am. J. Med. (Oct. 5 ): 135–142, 1984.
M’Buyamba-Kabangu, J. R., R. Fagard, P. Lijnen, and A. Amery. Nitrendipine and acebutolol in hypertensive African blacks. J. Cardiovasc. Pharmacol. 9(Suppl.4): 5263S266, 1987.
McCarron, D. A. and Morris, C. D. The calcium deficiency hypothesis of hypertension. Ann. Intern. Med. 107: 919–922, 1987.
McCubbin, J. W., J. H. Green, and I. H. Page. Baroreceptor function in chronic renal hypertension. Circ. Res. 4: 205–210, 1956.
Meininger, G. A., V. M. Lubrano, and H. J. Granger. Hemodynamic and microvascular responses in the hindquarters during the development of renal hypertension in rats. Evidence for the involvement of an autoregulatory component. Circ. Res. 55: 609–622, 1984.
Meininger, G. A., L. K. Routh, and H. J. Granger. Autoregulation and vasoconstriction in the intestine during acute renal hypertension. Hypertension 7: 364–373, 1985.
Michel, M. C., P. A. Insel, 0.-E. Brodde. Renal u-adrenergic receptor alterations: a cause of essential hypertension. FASEB J. 3: 139–144, 1989.
Miller, E. D., A. I. Samuels, E. Haber, and A. C. Barger. Inhibition of angiotensin conversion in experimental renovascular hypertension. Science 177: 1108–1109, 1972.
Miller, R. J. Multiple calcium channels and neuronal function. Science 235: 46–52, 1987.
Monod, J., J. Wyman, J-P. Changeux. On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 12: 88–118, 1965.
Montal, M. Molecular anatomy and molecular design of channel proteins. FASEB J. 4: 2623–2635, 1990.
Moser, M., J. Lunn, and B. J. Materson. Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension. Am. J. Cardiol. 56: 101H - 104H, 1985.
Moser, M., J. Lunn, D. T. Nash, J. F. Burris, N. Winer, G. Simon, and N. D. Vlachakis. Nitrendipine in the treatment of mild to moderate hypertension. J. Cardiovasc. Pharmacol. 6: 51085 - S1089, 1984.
Munch, P. A., and A. M. Brown. Role of vessel wall in acute resetting of aortic baroreceptors. Am. J. Physiol. 248 (Heart Circ. Physiol. 17): H843 - H852, 1985.
Munoz-Ramirez, H., R. E. Chatelain, F. M. Bumpus, and P. A. Khairallah. Development of two-kidney Goldblatt hypertension in rats under dietary sodium restriction. Am. J. Physiol. 238 (Heart Circ. Physiol. 7 ): H889 - H894, 1980.
Nabika, T., P. A. Velletri, M. A. Beaven, J. Endo, and W. Lovenberg. Vasopressin-induced calcium increases in smooth muscle cells from spontaneously hypertensive rats. Life Sci. 37: 579–584, 1985.
Nagao, T., I. Yamaguchi, H. Narita, and H. Nakajima. Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals. Am. J. Cardiol. 56: 56H - 61H, 1985.
O’Rourke, R. A. Rationale for calcium entry-blocking drugs in systemic hypertension complicated by coronary artery disease. Am. J. Cardiol. 56: 34H - 40H, 1985.
Owen, A. The aetiology of essential hypertension: an hypothesis describing two categories. Med. Hypotheses 19: 287–290, 1986.
Owens, G. K., and S. M. Schwartz. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ. Res. 53: 491–501, 1983.
Page, I. H. The mosaic theory 32 years later. Hypertension 7: 177, 1982.
Page, I. H. Initiation and maintenance of renal hypertension. Am. J. Surg. 107: 26–34, 1964.
Page, I. H. Neural and humoral control of blood vessels. In: Hypertension, edited by G. E. W. Wolstenholme and M. P. Cameron. Little, Brown, Boston, 1954, pp. 3–25.
Page, I. H., and J. W. McCubbin, eds. Renal Hypertension, Year Book, Chicago, 1968.
Pickering, T. G., and J. H. Laragh. Autoregulation as a factor in peripheral resistance and flow: clinical implications for analysis of high blood pressure. Am. J. Med. 68: 801–802, 1980.
Postnov, Y. V. An approach to the explanation of cell membrane alteration in primary hypertension. Hypertension 15: 332–337, 1990.
Postnov, Y. V., S. N. Orlov, G. M. Kravtsov, and P. V. Gulak. Calcium transport and protein content in cell plasma membranes of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 6: S21 - S27, 1984.
Postnov, Y. V., S. N. Orlov, and N. I. Pokudin. Alteration of intracellular calcium distribution in the adipose tissue of human patients with essential hypertension. Pflugers Arch. 388: 89–91, 1980.
Prewitt, R. L., D. L. Stacy, and Z. Ono. The microcirculation in hypertension: which are the resistance vessels? News in Physiological Sciences 2: 139–141, 1987.
Resink, T. J., V. A. Tkachuk, P. Erne, and F. R. Buhler. Platelet membrane calmodulinstimulated calcium-adenosine triophosphate. Altered activity in essential hypertension. Hypertension 8: 159–166, 1986.
Robertson, J. I. S., J. J. Morton, D. M. Tillman, and A. F. Lever. The pathophysiology of renovascular hypertension. J. Hypertens. 4 (Suppl. 4): S95 - S103, 1986.
Robertson, P. W., A. Klidjian, L. K. Harding, G. Walters, M. R. Lee, A. H. T. Robb-Smith. Hypertension due to a renin-secreting renal tumour. Am. J. Med. 43: 963–976, 1967.
Robinson, B. F. Altered calcium handling as a cause of primary hypertension. J. Hyper-tens. 2: 453–460, 1984.
Robinson, B. F., and R. J. W. Phillips. Effects of small increments in plasma calcium concentration on the responsiveness of forearm resistance vessels to verapamil in normal subjects. Clin. Sci. 67: 613–618, 1984.
Rogart, R. B., A. DeB Kops, and V.J. Dzau. Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane. Proc. Natl. Acad. Sci. U.S.A. 83: 7452–7456, 1986.
Rubin, L. J., P. Nicod, L. D. Hillis, and B. G. Firth. Treatment of primary pulmonary hypertension with nifedipine. Ann. Intern. Med. 99: 433–438, 1983.
Sachs, F. Baroreceptor mechanisms at the cellular level. Fed. Proc. 46: 12–16, 1987.
Sadoshima, S., F. Yoshida, S. Ibayashi, O. Shiokawa, and M. Fujishima. Upper limit of cerebral autoregulation during development of hypertensive rats: effect of sympathetic denervation. Stroke 16: 477–481, 1985.
Safer, M. E., A. C. Simon, J. A. Leuenson, and J. L. Cazor. Hemodynamic effects of diltiazen in hypertension. Circ. Res. 52 (Suppl. I): 169–173, 1983.
Sang, K. H. L. Q., and M.-A. Devynck. Increased platelet cytosolic free calcium concentration in essential hypertension. J. Hypertens. 4: 567–574, 1986.
Scheid, C. R., and F. S. Fay. Beta-adrenergic effects of transmembrane 45Ca fluxes in isolated smooth muscle cells. Am. J. Physiol. 246 (Cell Physiol. 15): C431 - C438, 1984.
Schiffrin, E. L., M. Lis, J. Gutkowska, and J. Genest. Role of Ca“ in response of adrenal glomerulosa cells to angiotensin II, ACTH, K+, and ouabain. Am. J. Physiol. 241 (Endocrinol. Metab. 4): E42 - E46, 1981.
Smith, S. G., A. A. Seymour, E. K. Mazack, J. Boger, and E. H. Blaine. Comparison of a new renin inhibitor and enalaprilat in renal hypertensive dogs. Hypertension 9: 150–156, 1987.
Snowdowne, K. W. The effect of stretch on sarcoplasmic free calcium of frog skeletal muscle at rest. Biochim. Biophys. Acta 862: 441–444, 1986.
Speden, R. N. Active reactions of the rabbit ear artery to distension. J. Physiol. (Lond.) 351: 631–643, 1984.
Spieker, C., W. Zidek, H. Lange-Asschenfeldt, H. Losse, and H. Vetter. Essential hypertension versus secondary hypertension discrimination by intracellular electrolytess. Klin. Worchenschr. 63 (Suppl.): 20–22, 1985.
Stephens, G. A., J. O. Davis, R. H. Freeman, J. M. DeForrest, and D. M. Early. Hemodynamic, fluid, and electrolyte changes in sodium-depleted, one-kidney, renal hypertensive dogs. Circ. Res. 44: 316–321, 1979.
Stienen, G. J. M., T. Blange, and B. W. Treijte. Tension development and calcium sensitivity in skinned muscle fibers of the frog. Pflugers Arch. 405: 19–23, 1985.
Sunderrajan, S., G. Reams, and J. H. Bauer. Renal effects of diltiazem in primary hypertension. Hypertension 8: 238–242, 1986.
Takaya, J., N. Lasker, R. Bamforth, M. Gutkin, L. H. Byrd, and A. Aviv. Kinetics of Ca“ -ATPase activation in platelet membranes of essential hypertensives and normotensives. Am. J. Physiol. 258 (Cell Physiol. 27): C988 - C994, 1990.
Taylor, A., and E. E. Windhager. Possible role of cytosolic calcium and Na-Ca exchange in regulation of transepithelial sodium transport. Am. J. Physiol. 236 (Renal Fluid Electrolyte Physiol. 5): F505–F512, 1979.
Thoren, P., M. C. Andresen, and A. M. Brown. Effects of changes in extracellular ionic concentrations on aortic baroreceptors with nonmyelinated afferent fibers. Circ. Res. 50: 413–418, 1982.
Tobian, L. Interrelationship of electrolytes, juxtaglomerular cells and hypertension. Physiol. Rev. 40: 280–312, 1960.
Tobian, L., and G. Chesley. Calcium content of arteriolar walls in normotensive and hypertensive rats. Proc. Soc. Exp. Biol. Med. 121: 340–343, 1966.
Tracy, R. E. and E. O. Overll. Arterioles of perfusion-fixed hypertension and aged kidneys. Arch. Pathol. 82: 529, 1966.
Trippodo, N. C., G. M. Walsh, R. A. Ferrone, and R. C. Dugan. Fluid partition and cardiac output in volume-depleted Goldblatt hypertensive rats. Am. J. Physiol. 237 (Heart Circ. Physiol. 6): H18 - H24, 1979.
Van Breemen, C., S. Lukeman, and C. Cauvin. A theoretical consideration on the use of calcium antagonists in the treatment of hypertension. Am. J. Med. Oct 5: 26–30, 1984.
Van Breemen, C., P. Leijten, H. Yamamoto, P. Aaronson, and C. Cauvin. Calcium activation of vascular smooth muscle. Hypertension 8(Suppl. II): II-89-II-95, 1986.
Vanhoutte, P. M. Calcium-entry blockers, vascular smooth muscle and systemic hypertension. Am. J. Cardiol. 55: 17B - 23B, 1985.
Vetter, H., W. Vetter, C. Warnholz, J. M. Bayer, H. Kaser, K. Vielhaber, and F. Kruck. Renin and aldosterone secretion in pheochromocytoma. Am. J. Med. 60: 866–871, 1976.
Weidmann, P., A. Gerber, and K. Laederach. Calcium antagonists in the treatment of hypertension: a critical overview. Adv. Nephrol. 14: 197–232, 1984.
Williams, R. R., S. C. Hunt, S. J. Hasstedt, P. N. Hopkins, L. W. Wu, T. D. Berry, and H. Kuida. Current knowledge regarding the genetics of human hypertension. J. Hyper-tens. 7 (Supp1.6): 8–13, 1989.
Windhager, E., G. Frindt, J. M. Yang, and C. O. Lee. Intracellular calcium ions as regulators of renal tubular sodium transport. Klin. Worchenschr. 64: 847–852, 1986.
Worley, J. F., J. W. Deitmer, and M. T. Nelson. Single nisoldipine-sensitive calcium channel in smooth muscle cells isolated from rabbit mesenteric artery. Proc. Natl. Acad. Sci. U.S.A. 83: 5746–5750, 1986.
Wright, C. E., J. A. Angus, and P. I. Korner. Vascular amplifier properties in renovascular hypertension in conscious rabbits. Hindquarter responses to constrictor and dilator stimuli. Hypertension 9: 122–131, 1987.
Wright, G. L., and G. O. Rankin. Concentrations of ionic and total calcium in plasma of four models of hypertension. Am. J. Physiol. 243 (Heart Circ. Physiol. 12): H365 - H370, 1982.
Yokoyama, S., N. Mori, T. Shingu, K. Sakata, T. Iwase, H. Yoshida, S. Takayama, T. Hoshino, and T. Kaburagi. Clinical effects of intravenous diltiazem hydrochloride on renal hemodynamics. J. Cardiovasc. Pharmacol. 9: 311–316, 1987.
Young, M. A., R. D. S. Watson, and W. A. Littler. Baroreflex setting and sensitivity after acute and chronic nicardipine therapy. Clin. Sci. 66: 233–235, 1984.
Zawada, E. T., and M. Johnson. Calcium chelation and calcium-channel blockade in anesthetized acute renovascular hypertensive dogs. Min. Electrolyte Metab. 10: 366–370, 1984.
Zemel, M. B., S. M. Gualdoni, M. F. Walsh, P. Komanicky, P. Standley, D. Johnson, W. Fitter, and J. R. Sowers. Effects of sodium and calcium on calcium metabolism and blood pressure regulation in hypertensive black adults. J. Hypertens. 4(Suppl. 5): 5364–5366, 1986.
Zidek, W., C. Karoff, P. Baumgart, H. Losse, K. J. Fehske, W. Hacker, and H. Vetter. Intracellular sodium and calium during antihypertensive treatment. Klin. Wochenschr. 63(Suppl. III): 147–149, 1985.
Zidek, W., C. Karoff, H. Losse, and H. Vetter. Weight reduction and salt restriction in hypertension: effects on blood pressure and intracellular electrolytes. Klin. Wochenschr. 64: 1183–1185, 1986.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 American Physiological Society
About this chapter
Cite this chapter
Fray, J.C.S. (1993). Pathogenesis of Hypertension in Blacks: Features of an Equilibrium Model. In: Fray, J.C.S., Douglas, J.G. (eds) Pathophysiology of Hypertension in Blacks. Clinical Physiology Series. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7577-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7577-4_11
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-7577-4
eBook Packages: Springer Book Archive